Biofrontera (BFRI) Depreciation and Depletion (2020 - 2025)
Biofrontera's (BFRI) quarterly Depreciation and Depletion came in at $36000.0 in Q4 2025, down 5.26% year-on-year from $38000.0 in Q4 2024, and up 111.76% quarter-over-quarter from $17000.0 in Q3 2025.
Biofrontera (BFRI) Depreciation and Depletion (2020 - 2025) Analysis & Trends
Biofrontera's Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $36000.0 for Q4 2025.
- On a quarterly basis, Depreciation and Depletion fell 5.26% year-over-year to $36000.0 in Q4 2025; TTM through Dec 2025 was $100000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $100000.0, changed 0.0% from the prior year.
- Depreciation and Depletion rose to $36000.0 in Q4 2025 per BFRI's latest filing, from $17000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $38000.0 in Q4 2024 and bottomed at $17000.0 in Q3 2025.
- The 5-year median for Depreciation and Depletion is $23500.0 (2023), against an average of $25350.0.
- Across the five-year window, Depreciation and Depletion decreased 22.86% in 2021 and soared 80.95% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $27000.0 in 2021, then slipped by 22.22% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then surged by 80.95% to $38000.0 in 2024, then slipped by 5.26% to $36000.0 in 2025.
- Per Business Quant, the three latest BFRI Depreciation and Depletion figures stand at $36000.0 (Q4 2025), $17000.0 (Q3 2025), and $22000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |